PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2017.1262018502366-373Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with SorafenibJeong-Ju Yoo, Goh Eun Chung, Jeong-Hoon Lee, Joon Yeul Nam, Young Chang, Jeong Min Lee, Dong Ho Lee, Hwi Young Kim, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, http://www.e-crt.org/upload/pdf/crt-2017-126.pdf, http://www.e-crt.org/journal/view.php?doi=10.4143/crt.2017.126, http://www.e-crt.org/upload/pdf/crt-2017-126.pdf
Hepatology Research10.1111/j.1872-034x.2012.00991.x2012429879-886Skin toxicities and survival in advanced hepatocellular carcinoma patients treated with sorafenibTaiga Otsuka, Yuichiro Eguchi, Seiji Kawazoe, Kimihiko Yanagita, Keisuke Ario, Kenji Kitahara, Hiroaki Kawasoe, Hiroyuki Kato, Toshihiko Mizuta, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1872-034X.2012.00991.x
Hepatology Research10.1111/hepr.126012015467650-656Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenibTakeshi Terashima, Tatsuya Yamashita, Noboru Takata, Hidetoshi Nakagawa, Tadashi Toyama, Kuniaki Arai, Kazuya Kitamura, Taro Yamashita, Yoshio Sakai, Eishiro Mizukoshi, Masao Honda, Shuichi Kanekohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fhepr.12601
Journal of Hepatology10.1016/s0168-8278(17)31709-92017661S630-S631Analysis of postprogression survival of patients with advanced hepatocellular carcinoma treated with sorafenibY. Wada, Y. Takami, H. Matsushima, T. Ryu, K. Mikagi, H. Saitsuhttps://api.elsevier.com/content/article/PII:S0168827817317099?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168827817317099?httpAccept=text/plain
Annals of Oncology10.1093/annonc/mdz155.384201930Supplement_4P-385PD-(L)1 inhibitors vs targeted therapy vs their combination as second-line treatment in patients with advanced hepatocellular carcinoma previously treated with sorafenibL Pan, X Caihttp://academic.oup.com/annonc/article-pdf/30/Supplement_4/mdz155.384/28892146/mdz155.384.pdf
Journal of Hepatocellular Carcinoma10.2147/jhc.s1692852018Volume 5109-119Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)Hamdy Azim, Ashraf Omar, Hesham Atef, Heba Zawahry, Mohamed K Shaker, AH Kamel Abdelmaksoud, Mohamed EzzElarab, Omar Abdel-Rahman, Mohamed Ismail, Loay Kassem, Imam Wakedhttps://www.dovepress.com/getfile.php?fileID=46294, https://www.dovepress.com/getfile.php?fileID=46294
The Korean Journal of Hepatology10.3350/kjhep.2009.15.2.2272009152227Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinomaJeong Heohttp://synapse.koreamed.org/pdf/10.3350/kjhep.2009.15.2.227, http://synapse.koreamed.org/DOIx.php?id=10.3350/kjhep.2009.15.2.227
The Korean Journal of Hepatology10.3350/kjhep.2007.13.4.5762007134576The Efficacy of Sorafenib for Patients With Advanced Hepatocellular CarcinomaJeong Heohttp://synapse.koreamed.org/pdf/10.3350/kjhep.2007.13.4.576, http://synapse.koreamed.org/DOIx.php?id=10.3350/kjhep.2007.13.4.576
Practical Radiation Oncology10.1016/j.prro.2013.01.098201332S29Feasibility Study of 4D Perfusion CT for Hepatocellular Carcinoma Patients Treated With Radiation and SorafenibC. Coolens, B. Driscoll, L. Dawsonhttps://api.elsevier.com/content/article/PII:S187985001300101X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S187985001300101X?httpAccept=text/plain
Journal of Hepatology10.1016/s0168-8278(11)60663-6201154S266-S267661 BIOLOGICAL DOWNSTAGING OF INTERMEDIATE HEPATOCELLULAR CARCINOMA IN PATIENTS TREATED WITH SORAFENIB: FINAL REPORT OF A PROSPECTIVE STUDYA. Vitale, R.R. Morales, U. Ciliohttps://api.elsevier.com/content/article/PII:S0168827811606636?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168827811606636?httpAccept=text/plain